Device Trial Radar · NCT07499063
Effect of Exoskeleton-Assisted Walking on Gait Parameters in Healthy Adults
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
May 10, 2026
Primary completion
Jun 1, 2026
Study completion Aug 10, 2026
Sponsor
- Lead sponsor
- The State Academy of Applied Sciences in KoszalinAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 30, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated device
- No
- Who can join
- Female only, from 19 years, up to 25 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study investigated the immediate effects of a single session of EksoNR-assisted walking on gait parameters and plantar pressure distribution in healthy young adults. Participants underwent a baseline assessment using a baropodometric platform, followed by one supervised exoskeleton-assisted walking session and a post-intervention assessment. The study used a single-group pre-post design to examine short-term biomechanical changes associated with exoskeleton-assisted walking.
Conditions
- Gait Analysis in Healthy Subjects
Interventions
Ekso NR ExoskeletonDevice
A wearable robotic exoskeleton used to assist walking during a supervised 30-minute session.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in step lengthTime frame: Immediately before and immediately after the intervention.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
State Academy of Applied Sciences in Koszalin
Koszalin, West Pomeranian Voivodeship, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.